title: South African guidelines for the management of nocturnal enuresis.
authors.forename: J C
authors.initials: JC
authors.lastname: van Dyk
authors.forename: F
authors.initials: F
authors.lastname: Duvenhage
authors.forename: L J E
authors.initials: LJ
authors.lastname: Coetzee
authors.forename: A M
authors.initials: AM
authors.lastname: Segone
authors.forename: M
authors.initials: M
authors.lastname: Fockema
authors.forename: D
authors.initials: D
authors.lastname: Smart
authors.forename: M
authors.initials: M
authors.lastname: Haffejee
authors.forename: S B I
authors.initials: SB
authors.lastname: Lefakane
authors.forename: J
authors.initials: J
authors.lastname: Roos
authors.forename: G
authors.initials: G
authors.lastname: Stellmacher
authors.forename: D
authors.initials: D
authors.lastname: McGillevray
authors.forename: Z
authors.initials: Z
authors.lastname: Bereczky
mesh_terms: D000047:Academies and Institutes; D000929:Antidepressive Agents, Tricyclic; D002648:Child; D018680:Cholinergic Antagonists / Q000627:therapeutic use; D000075202:Contraindications; D003894:Deamino Arginine Vasopressin / Q000627:therapeutic use; D004775:Enuresis / Q000209:etiology / Q000378:metabolism / Q000503:physiopathology / Q000628:therapy*; D005260:Female; D006801:Humans; D008297:Male; D012076:Renal Agents / Q000627:therapeutic use; D020921:Sleep Arousal Disorders / Q000150:complications; D013019:South Africa; D001743:Urinary Bladder / Q000503:physiopathology; D014667:Vasopressins / Q000378:metabolism
chemical_list: D000929:Antidepressive Agents, Tricyclic; D018680:Cholinergic Antagonists; D012076:Renal Agents; D014667:Vasopressins; D003894:Deamino Arginine Vasopressin